Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Wegovy conducted a study with 1,900 adults who were obese or overweight with comorbidity (high blood pressure or high cholesterol) and found that people lost a median of 15% of their weight while on a target weight loss dose of medication (2.4 mg/week)
doi:10.1155/2011/376509 25
The study recruited participants through endometriosis advocacy platforms, social media, and clinical networks, targeting women aged 18 to 55 with confirmed or suspected endometriosis and current or prior GLP-1 medication use
Focus on trends over weeks and months rather than individual data points
US$ 21.84
US$ 23.20
US$ 21.22
US$ 27.62
US$ 28.75
